ADAP Crisis Task Force Announces Continued Partnership with Bristol-Myers Squibb and Boehringer Ingelheim for AIDS Drug Assistance Programs in the United States

FOR IMMEDIATE RELEASE
Contact: Murray Penner
202-434-8090
mpenner@NASTAD.org

ADAP AlertOctober 28, 2013, Washington, DC – The ADAP Crisis Task Force (Task Force) announced today that it has reached agreement with Bristol-Myers Squibb (BMS) and Boehringer Ingelheim (BI) to extend voluntary discounts/rebates and price freezes to all state AIDS Drug Assistance Programs (ADAPs).  The continuation of existing agreements beyond 2013 will provide stability to ADAPs as they continue to navigate the uncharted terrain of a reformed health system as a result of implementation of the Affordable Care Act (ACA) and continued fiscal challenges at both the state and federal level.

The Task Force, convened by the National Alliance of State and Territorial AIDS Directors (NASTAD), previously secured continuation through 2014 of existing agreements for voluntary discounts and rebates from AbbVie, Gilead Sciences, Janssen Therapeutics, Merck and ViiV Healthcare.  Many of these agreements also provide continued price freezes for ADAPs for varying lengths of time into 2014 and 2015.  Continue reading

ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for Tivicay®

FOR IMMEDIATE RELEASE
Contact: Meico Whitlock
202-434-8090

ADAP Crisis Task Force Announces Agreement with ViiV Healthcare for TivicayAugust 26, 2013, Washington, DC – The ADAP Crisis Task Force (ACTF) has reached a new pricing agreement with ViiV Healthcare for AIDS Drug Assistance Programs (ADAPs) for Tivicay® (dolutegravir) for the treatment of HIV-1 infected individuals. The agreed-upon ADAP direct purchase price for Tivicay®, negotiated between the ACTF and ViiV, is substantially lower than the wholesale acquisition cost (WAC), reflecting voluntary discounts that are also significantly below the mandated 340B pricing of the medication.

Continue reading

ADAP Crisis Task Force Announces Agreement with Industry Partners

FOR IMMEDIATE RELEASE
Contact: Murray Penner
202-434-8090
mpenner@NASTAD.org

ADAP Crisis Task ForceJuly 29, 2013, Washington, DC – As part of ongoing efforts by the ADAP Crisis Task Force (Task Force) and the pharmaceutical industry to address the continued need for access to HIV antiretroviral medicines through AIDS Drug Assistance Programs (ADAPs), the Task Force announced today that it has reached agreement with AbbVie, Gilead Sciences, Merck, and ViiV Healthcare to extend the voluntary discounts/rebates and price freezes available to all state ADAPs through December 31, 2014.

Continue reading

NASTAD Applauds Supreme Court Rulings on Same-Sex Marriage

FOR IMMEDIATE RELEASE: June 26, 2013
Contact: Meico Whitlock, 202-434-8094, www.NASTAD.orgNASTAD Gay's Men's Health Equity

Supreme Court Decisions on California’s Proposition 8 and the Defense of Marriage Act (DOMA) Represent Tremendous Progress for Gay Men’s Health Equity; Still Much Work to Do to Achieve Full Equality for People of All Races, Ethnicities and Sexual Orientations

Washington, DC – Today’s Supreme Court rulings on California’s Proposition 8 and the Defense of Marriage Act (DOMA) align with NASTAD’s ongoing efforts to address health equity among gay men and other men who have sex with men (MSM) of all races and ethnicities. The National HIV/AIDS Strategy (NHAS) and NASTAD’s policy statement on gay men/MSM both stress the importance of reducing stigma related to HIV/AIDS, and routinizing HIV care as a part of overall health care. NASTAD’s work in reducing the stigma faced by gay men/MSM, and addressing structural barriers that lead to poor health outcomes among gay men/MSM are significantly advanced by a social recognition that same-sex unions are valuable and worth codifying. Continue reading

Former Massachusetts Commissioner of Public Health John Auerbach Honored with Lifetime Achievement Award for Unwavering Leadership in Response to the Domestic HIV/AIDS Epidemic

FOR IMMEDIATE RELEASE: June 7, 2013
Contact: Meico Whitlock, 202-434-8094, www.NASTAD.org

Julie Scofield and John Auerbach

Julie Scofield, NASTAD Executive Director and John Auerbach

Washington, DC – The National Alliance of State and Territorial AIDS Directors (NASTAD) recognized John Auerbach with its Lifetime Achievement Award at its 22nd Annual Meeting of state health department HIV and hepatitis program leaders last month. The meeting takes place every May in Washington, D.C.

Mr. Auerbach is the former Massachusetts Commissioner of Public Health where he oversaw more than 3,000 employees that included four public health hospitals, the State Laboratory, several regulatory bodies, and numerous programmatic units addressing chronic and infectious disease, substance abuse, environmental health, tobacco control, children and adolescent health, and emergency preparedness. Continue reading